Indivior reported 667M in Current Assets for its fiscal semester ending in March of 2026.





Current Assets Change Date
AstraZeneca USD 27.97B 1.65B Jun/2026
Cassava Sciences USD 87.96M 9.74M Mar/2026
GlaxoSmithKline GBP 17.56B 202M Jun/2026
Glaxosmithkline GBP 17.76B 5.83B Mar/2026
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Roche Holding CHF 35.44B 3.29B Jun/2026
West Pharmaceutical Services USD 1.81B 19.3M Jun/2026